• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人促红细胞生成素对慢性肾衰竭自发性高血压大鼠血压及肾功能的影响。

Effects of recombinant human erythropoietin on blood pressure and renal function in SHR with chronic renal failure.

作者信息

Kohzuki M, Yasujima M, Kanazawa M, Yoshida K, Sato T, Abe K

机构信息

Section of Internal Medicine and Disability Prevention, Tohoku University Graduate School, Sendai, Japan.

出版信息

Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S165-6. doi: 10.1111/j.1440-1681.1995.tb02865.x.

DOI:10.1111/j.1440-1681.1995.tb02865.x
PMID:9072339
Abstract
  1. The effects of chronic administration of erythropoietin (EPO) on blood pressure and renal function in rats with ablation of renal mass were assessed. 2. Spontaneously hypertensive rat were subjected to 5/6 nephrectomy (5/6Nx). Four weeks after the operation, the rats were randomly allocated to vehicle, EPO 20IU/kg i.p., or EPO 100 IU/kg i.p. (both given twice a week) for 4 weeks. 3. Marked anaemia was noted in SHR-5/6Nx. EPO caused a significant increase in haematocrit at a high dose but not at a low dose. A dose dependent relationship was noted in the EPO-induced rise in the systolic blood pressure. 4. EPO dose-dependently increased urinary protein excretion. It also increased blood urea nitrogen and serum creatinine levels. 5. These results suggest that EPO ameliorates anaemia and severely accelerates renal failure in SHR-5/6Nx. They also suggest that anaemia can be a haemodynamically favorable adaptation to chronic renal disease and that its correction may have adverse renal haemodynamic and structural consequences.
摘要
  1. 评估了长期给予促红细胞生成素(EPO)对肾大部切除大鼠血压和肾功能的影响。2. 将自发性高血压大鼠进行5/6肾切除术(5/6Nx)。术后4周,将大鼠随机分为三组,分别给予溶剂对照、腹腔注射20IU/kg EPO或腹腔注射100IU/kg EPO(均每周给药两次),持续4周。3. 在SHR-5/6Nx大鼠中观察到明显贫血。高剂量EPO可显著提高血细胞比容,但低剂量则无此作用。EPO引起的收缩压升高呈剂量依赖性。4. EPO剂量依赖性增加尿蛋白排泄。它还增加了血尿素氮和血清肌酐水平。5. 这些结果表明,EPO可改善SHR-5/6Nx大鼠的贫血,但会严重加速肾衰竭。它们还表明,贫血可能是对慢性肾病的一种血液动力学上有利的适应性反应,纠正贫血可能会对肾脏血液动力学和结构产生不良后果。

相似文献

1
Effects of recombinant human erythropoietin on blood pressure and renal function in SHR with chronic renal failure.重组人促红细胞生成素对慢性肾衰竭自发性高血压大鼠血压及肾功能的影响。
Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S165-6. doi: 10.1111/j.1440-1681.1995.tb02865.x.
2
The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model.
Nephrol Dial Transplant. 1998 Sep;13(9):2210-5. doi: 10.1093/ndt/13.9.2210.
3
Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose.残余肾大鼠模型中重组人促红细胞生成素治疗的肾脏风险效益决定因素——高血压、贫血、炎症和药物剂量。
Clin Exp Pharmacol Physiol. 2016 Mar;43(3):343-54. doi: 10.1111/1440-1681.12541.
4
Progression of anemia and its relationship with renal function, blood pressure, and erythropoietin in rats with chronic kidney disease.慢性肾脏病大鼠贫血的进展及其与肾功能、血压和促红细胞生成素的关系。
Vet Clin Pathol. 2015 Sep;44(3):342-54. doi: 10.1111/vcp.12276. Epub 2015 Aug 20.
5
Endothelin-mediated effect of erythropoietin on blood pressure and renal hemodynamics in hypertensive rats.内皮素介导的促红细胞生成素对高血压大鼠血压和肾血流动力学的影响。
Am J Physiol. 1996 Apr;270(4 Pt 2):R744-8. doi: 10.1152/ajpregu.1996.270.4.R744.
6
Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis.促红细胞生成素在肾部分切除大鼠主动脉中的作用不仅限于造血,还可预防血管炎症和氧化应激。
Clin Exp Pharmacol Physiol. 2010 Dec;37(12):1139-46. doi: 10.1111/j.1440-1681.2010.05445.x.
7
Role of renal kallikrein in the regulation of blood pressure in the rat remnant kidney model of chronic renal failure.肾激肽释放酶在大鼠慢性肾衰竭残余肾模型血压调节中的作用。
Adv Exp Med Biol. 1989;247B:121-5. doi: 10.1007/978-1-4615-9546-5_20.
8
Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.促红细胞生成素治疗纠正贫血可延缓慢性肾衰竭的进展,尤其是在非糖尿病患者中。
Nephron. 1997;77(2):176-85. doi: 10.1159/000190270.
9
Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients.重组人促红细胞生成素治疗对透析前患者慢性肾衰竭进展速率的有益影响。
Nephrol Dial Transplant. 2001 Feb;16(2):307-12. doi: 10.1093/ndt/16.2.307.
10
Recombinant human erythropoietin in predialysis patients.重组人促红细胞生成素用于透析前患者
Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):34-7.

引用本文的文献

1
Protective effect of Epo on oxidative renal injury in rats with cyclosporine nephrotoxicity.促红细胞生成素对环孢素肾毒性大鼠氧化肾损伤的保护作用。
Pediatr Nephrol. 2008 Nov;23(11):1991-9. doi: 10.1007/s00467-008-0903-1. Epub 2008 Jul 11.